[go: up one dir, main page]

BR9815248A - Sistema monolìtico contendo um ou mais medicamentos, consistindo de três camadas com diferentes mecanismos de liberação - Google Patents

Sistema monolìtico contendo um ou mais medicamentos, consistindo de três camadas com diferentes mecanismos de liberação

Info

Publication number
BR9815248A
BR9815248A BR9815248-3A BR9815248A BR9815248A BR 9815248 A BR9815248 A BR 9815248A BR 9815248 A BR9815248 A BR 9815248A BR 9815248 A BR9815248 A BR 9815248A
Authority
BR
Brazil
Prior art keywords
drugs
layers
system containing
release mechanisms
different release
Prior art date
Application number
BR9815248-3A
Other languages
English (en)
Inventor
Paolo Chiesi
Daniela Acerbi
Rossella Musa
Ruggero Bettini
Giovanni Caponetti
Luigi Catellani Pier
Paolo Ventura
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BR9815248A publication Critical patent/BR9815248A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

SISTEMA DE MONOLìTICO CONTENDO UM OU MAIS MEDICAMENTOS, CONSISTINDO DE TRêS CAMADAS COM DIFERENTES MECANISMOS DE LIBERAçãO Um sistema monolítico de liberação controlada para administração oral está aqui descrito, compreendendo uma camada de desintegração, uma camada de erosão e uma camada de intumescência, das quais, duas são externas e uma é intermediária, cada camada contendo um ou mais medicamentos. Sua propriedades de liberação e processos de preparação estão também descritos aqui.-
BR9815248-3A 1997-10-03 1998-10-01 Sistema monolìtico contendo um ou mais medicamentos, consistindo de três camadas com diferentes mecanismos de liberação BR9815248A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI002254A IT1295271B1 (it) 1997-10-03 1997-10-03 Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
PCT/EP1998/006228 WO1999017745A1 (en) 1997-10-03 1998-10-01 Monolithic system containing one or more drugs, consisting of three layers with different release mechanisms

Publications (1)

Publication Number Publication Date
BR9815248A true BR9815248A (pt) 2000-11-21

Family

ID=11377984

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815248-3A BR9815248A (pt) 1997-10-03 1998-10-01 Sistema monolìtico contendo um ou mais medicamentos, consistindo de três camadas com diferentes mecanismos de liberação

Country Status (14)

Country Link
EP (1) EP1019029B1 (pt)
AR (1) AR043070A1 (pt)
AT (1) ATE248590T1 (pt)
AU (1) AU9629198A (pt)
BR (1) BR9815248A (pt)
CZ (1) CZ298851B6 (pt)
DE (1) DE69817848T2 (pt)
ES (1) ES2205558T3 (pt)
HU (1) HU225692B1 (pt)
IT (1) IT1295271B1 (pt)
NO (1) NO20001709L (pt)
SK (1) SK284552B6 (pt)
WO (1) WO1999017745A1 (pt)
ZA (1) ZA989010B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002340470A1 (en) 2001-11-13 2003-05-26 Teva Pharmaceutical Industries, Ltd. L-dopa ethyl ester salts and uses thereof
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20080299204A1 (en) * 2005-06-23 2008-12-04 Spherics, Inc. Dosage forms for movement disorder treatment
ATE489079T1 (de) * 2005-12-29 2010-12-15 Osmotica Kereskedelmi Es Szolgaltata Kft Mehrschichtige tablette mit dreifacher freisetzungskombination
CN102202656A (zh) 2008-08-15 2011-09-28 蒂宝制药公司 治疗和预防cns障碍的胃滞留药用组合物
JP5905872B2 (ja) * 2010-04-07 2016-04-20 ルピン・リミテッド タペンタドールの制御放出医薬組成物
EP2508174A1 (en) 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
ITMI20121263A1 (it) * 2012-07-19 2014-01-20 Recordati Ind Chimica E Farma Ceutica S P A Forma farmaceutica multistrato
CN105431144A (zh) 2013-06-05 2016-03-23 思康脑侒股份有限公司 阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
CA2926082C (en) * 2013-10-07 2022-06-14 Impax Laboratories, Inc. Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
US9808478B2 (en) * 2015-04-17 2017-11-07 Steven Loyd Control release of fat soluble antioxidants from an oral formulation and method
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen
WO2022140448A1 (en) 2020-12-22 2022-06-30 Amneal Pharmaceuticals Llc Levodopa dosing regimen
CN117599009A (zh) * 2023-11-10 2024-02-27 长沙晶易医药科技股份有限公司 一种卡左双多巴三层片及其制备方法
CN118831063A (zh) * 2024-07-18 2024-10-25 泰州越洋医药开发有限公司 一种三层片制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili

Also Published As

Publication number Publication date
EP1019029A1 (en) 2000-07-19
SK284552B6 (sk) 2005-06-02
ZA989010B (en) 1999-04-12
NO20001709D0 (no) 2000-04-03
EP1019029B1 (en) 2003-09-03
DE69817848D1 (de) 2003-10-09
AU9629198A (en) 1999-04-27
ITMI972254A1 (it) 1999-04-03
NO20001709L (no) 2000-06-05
IT1295271B1 (it) 1999-05-04
HUP0004015A2 (hu) 2001-08-28
SK4822000A3 (en) 2000-09-12
CZ298851B6 (cs) 2008-02-27
ATE248590T1 (de) 2003-09-15
DE69817848T2 (de) 2005-04-07
HU225692B1 (en) 2007-06-28
WO1999017745A1 (en) 1999-04-15
AR043070A1 (es) 2005-07-20
ES2205558T3 (es) 2004-05-01
HUP0004015A3 (en) 2006-06-28
CZ20001200A3 (cs) 2000-09-13

Similar Documents

Publication Publication Date Title
BR9815248A (pt) Sistema monolìtico contendo um ou mais medicamentos, consistindo de três camadas com diferentes mecanismos de liberação
NO305907B1 (no) Forbindelser, forbindelser for bekjempelse av sykdommer, legemidler som endotelinreseptorantagonist, farmasöytiske preparater samt anvendelse av slike forbindelser til fremstilling av legemidler
NO305906B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
ATE177630T1 (de) Gegen missbrauch geschuetzte tabletten
EE200000380A (et) 11ß-halogeno-7(alfa)-asendatud östratrieenid, neid 11ß-halogeno-7(alfa)-asendatud östratrieene sisaldavate farmatseutiliste preparaatide valmistamise meetodid ja nende kasutamine ravimite valmistamiseks
CA2145513A1 (en) Pharmaceutical Tablet Capable of Liberating One or More Drugs at Different Release Rates
SE9702533D0 (sv) New oral formulation
BR9808325A (pt) Formas de dosagem compreendendo porções separadas de r- e senanciÈmeros
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
DE3689252D1 (de) Arzneimittel gegen chronische Graft-versus-Host-Krankheiten sowie gegen Autoimmunerkrankungen, insbesondere systemischen Lupus erythematodes.
NO971206D0 (no) Forlenget-frigjöringsformulering
ES2090368T3 (es) Composiciones farmaceuticas que contienen glucosaminoglicanos absorbibles por via oral.
EE9900441A (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks
KR880010758A (ko) 서방성 제제
KR850700212A (ko) 서방성 약제학적 캼셀제
NO306113B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
NL193820B (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
NO305836B1 (no) Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
IT8621097A0 (it) Composizioni farmaceutiche. derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI